Cargando…

Grading of prostate cancer: a work in progress

Grading of prostate cancer has evolved substantially over time, not least because of major changes in diagnostic approach and concomitant shifts from late‐ to early‐stage detection since the adoption of PSA testing from the late 1980s. After the conception of the architecture‐based nine‐tier Gleason...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kweldam, C F, van Leenders, G J, van der Kwast, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380027/ https://www.ncbi.nlm.nih.gov/pubmed/30565302 http://dx.doi.org/10.1111/his.13767

Ejemplares similares

On cribriform prostate cancer
por: Kweldam, Charlotte F., et al.
Publicado: (2018)

Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens
por: Rijstenberg, L. Lucia, et al.
Publicado: (2020)

Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
por: Hoogland, A. Marije, et al.
Publicado: (2014)

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations
por: Böttcher, René, et al.
Publicado: (2018)

The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
por: van Leenders, Geert J.L.H., et al.
Publicado: (2020)

Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern
por: van der Slot, Margaretha A., et al.
Publicado: (2022)

Automated detection of cribriform growth patterns in prostate histology images
por: Ambrosini, Pierre, et al.
Publicado: (2020)

Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading
por: van Leenders, Geert J L H, et al.
Publicado: (2020)

Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies
por: Rijstenberg, L Lucia, et al.
Publicado: (2022)

Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer
por: Ghai, Sangeet, et al.
Publicado: (2017)

Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer
por: Böttcher, René, et al.
Publicado: (2015)

MET expression during prostate cancer progression
por: Verhoef, Esther I., et al.
Publicado: (2016)

Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
por: Kamdar, Shivani, et al.
Publicado: (2019)

Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading
por: Egevad, Lars, et al.
Publicado: (2020)

Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy
por: Seyrek, Neslisah, et al.
Publicado: (2022)

Predicting biochemical recurrence and prostate cancer‐specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening‐ and clinically detected prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2019)

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy
por: Hollemans, Eva, et al.
Publicado: (2020)

Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer
por: Hoogland, A. Marije, et al.
Publicado: (2016)

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
por: Bulten, Wouter, et al.
Publicado: (2022)

Work-relatedness of inguinal hernia: a systematic review including meta-analysis and GRADE
por: Kuijer, P. P. F. M., et al.
Publicado: (2020)

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer
por: Rodríguez-Blanco, Giovanny, et al.
Publicado: (2018)

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis
por: Hollemans, Eva, et al.
Publicado: (2018)

Accumulating Progenitor Cells in the Luminal Epithelial Cell Layer Are Candidate Tumor Initiating Cells in a Pten Knockout Mouse Prostate Cancer Model
por: Korsten, Hanneke, et al.
Publicado: (2009)

Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
por: Seyrek, Neslisah, et al.
Publicado: (2021)

The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression
por: Schroten, Caroline, et al.
Publicado: (2011)

Work‐relatedness of lateral epicondylitis: Systematic review including meta‐analysis and GRADE work‐relatedness of lateral epicondylitis
por: Bretschneider, S. Fransje, et al.
Publicado: (2021)

Intraductal Carcinoma of the Prostate: To Grade or Not to Grade
por: Surintrspanont, Jerasit, et al.
Publicado: (2023)

Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice
por: Korsten, Hanneke, et al.
Publicado: (2016)

E17K substitution in AKT1 in prostate cancer
por: Boormans, J L, et al.
Publicado: (2010)

Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens
por: Nagpal, Kunal, et al.
Publicado: (2020)

Synchronous Penile Metastasis from a High-Grade Adenocarcinoma of the Prostate
por: Dijkstra, S., et al.
Publicado: (2012)

Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer()
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2017)

MRI grading for the prediction of prostate cancer aggressiveness
por: Boschheidgen, M., et al.
Publicado: (2021)

Androgen receptor profiling predicts prostate cancer outcome
por: Stelloo, Suzan, et al.
Publicado: (2015)

Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer
por: Kolijn, Kimberley, et al.
Publicado: (2015)

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches
por: Verhoeven, Marjolein, et al.
Publicado: (2023)

The telomere length landscape of prostate cancer
por: Livingstone, Julie, et al.
Publicado: (2021)

Role of the DNA damage response in prostate cancer formation, progression and treatment
por: Zhang, Wenhao, et al.
Publicado: (2019)

Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse
por: Fraser, Michael, et al.
Publicado: (2021)

Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues
por: Schaik, R H N van, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_dll0lhr22s15qefakvcvvid15v